Navigation Links
VaxGen in Medical News

FDA Warns VaxGen On Anthrax Vaccine

The Food and Drug Administration has warned the manufacturers of a new vaccine for anthrax for making false claims about the purity and effectiveness// of the vaccine. VaxGen Inc was accused of inflating the claims based on a few studies, the data for which is not enough for issuing such statements...

VaxGen Provides Financial Update Following the Filing of Its 10-Q for Second Quarter With SEC; Results Include $8.5 Million Charge in Respect of Manufacturing Plant Asset Impairment

...w.newscom.com/cgi-bin/prnh/19991112/VAXGENLOGO ) vaxgen had approximately $59 million in cash and equivale...any's $30 million of outstanding convertible debt. vaxgen reported a net loss for the second quarter of $10....agreed to terms, for reasons entirely unrelated to vaxgen or the plant. In light of this, however, our expec...

New HIV browser gives researchers access to valuable data from vaccine trials

...raphic and clinical data from volunteers who became HIV infected during the vaxgen clinical trial. The browser allows users to align viral sequences with one ...quence data from infected participants in the Phase III clinical trial that vaxgen conducted in Thailand. "In the future, the database will be expanded to...

VaxGen Restructures Following Termination of Proposed Merger

...ger between VaxGen and Raven biotechnologies, inc. vaxgen has moved to terminate the staff which it had reta...n of the needs of the merged company. As a result, vaxgen will be terminating approximately 75% of its remai...91112/VAXGENLOGO ) "It is quite unfortunate that vaxgen must now terminate so many of our most capable and...

VaxGen Provides Updates and Encourages Stockholders to Vote In Favor of Proposed Merger With Raven

.../ -- VaxGen Inc. (OTC Bulletin Board: VXGN) Dear vaxgen Stockholder, March 28th marks the date of the Sp...cial Stockholder meeting and the conclusion of the vaxgen stockholder vote on the proposed VaxGen-Raven merg...ity of the votes cast in person or by proxy at the vaxgen special meeting is required for approval of the me...

VaxGen and Raven biotechnologies Announce Signing of Definitive Merger Agreement

...sed Transaction Under the terms of the agreement, vaxgen shall issue, and the holders of Raven Series D pre...ee transaction, approximately 32 million shares of vaxgen common stock. Following the closing of the transaction, vaxgen stockholders will own approximately 51 percent of ...

An alternative vaccine to combat Anthrax

...e using this data to help design strategies for testing of this vaccine in the future." Gorse indicated that the investigational vaccine, made by vaxgen Inc., demonstrated a clear relationship between the amount of vaccine administered and the subsequent immune response. The study was designed to e...

Two AIDS Vaccine Trials Hold Hope Against Epidemic

...n South America and the Caribbean, is an improvement over the disappointing vaxgen that came to a dead end in Thailand in 2003, Koff said. Tests on the ...y miraculous," Nabel told DPA. In addition, a modified version of the vaxgen trials continues on 16,000 volunteers in Thailand, who are receiving an add...
VaxGen in Medical Technology

Raven Announces Initiation of a RAV12 Phase 2 Clinical Trial in Metastatic Pancreatic Cancer

...therapeutic MAbs for many cancer indications including lung, colon, pancreatic, prostate, breast and ovarian cancer. On November 12, 2007, Raven and vaxgen Inc. (OTC: VXGN.PK), a biopharmaceutical company, announced that their respective boards of directors unanimously approved a definitive merger agreeme...

GeoVax Vaccine Only 5th AIDS Vaccine Moving to Phase 2 Human Trials

...ials. Only a handful of AIDS vaccines have reached the Phase 2 level of clinical evaluation with the HVTN, including the previously failed vaccines of vaxgen and Merck," stated GeoVax President, Don Hildebrand. GeoVax has completed two Phase 1 human trials evaluating its AIDS vaccines with excellent resul...

ImmuneRegen BioSciences Reports Material Transfer Agreement with VaxGen, Inc.

..., today announced it has finalized a Material Transfer Agreement (MTA) with vaxgen Inc. (Pink Sheets: VXGN.PK). As part of the agreement, ImmuneRegen will rec...nd, Viprovex, will demonstrate adjuvant activity in a rabbit model with the vaxgen vaccine," said Hal Siegel, Ph.D., Senior Director of Product Development an...
VaxGen in Biological News

Combating anthrax: Results of study published this month as researchers look for a better vaccine

... be using this data to help design strategies for testing of this vaccine in the future." Gorse indicated that the investigational vaccine, made by vaxgen Inc., demonstrated a clear relationship between the amount of vaccine administered and the subsequent immune response. The study was designed to ev...
VaxGen in Biological Technology

VaxGen Restructures Board of Directors

.../VAXGENLOGO ) In conjunction with these changes, vaxgen is reconstituting the Strategic Transactions Commi...logy transaction experience." said James P. Panek, vaxgen President and CEO. "I am delighted to welcome two ...ice over the past several years." About VaxGen vaxgen is a biopharmaceutical company based in South San ...

Vaxgen Files 10-Q for First Quarter With SEC, Provides Future Burn Rate Guidance

... recent restructuring undertaken on April 9, 2008. vaxgen expects that its average monthly cash expenditures... the Company's sole control," said James P. Panek, vaxgen President and CEO. "While we continue to explore e...ovide assurance that a transaction will result." vaxgen further announced today the filing of its financia...

VaxGen Sells Anthrax Vaccine Program and Related Assets and Technology to Emergent BioSolutions, Inc.

...rms of the transaction, Emergent BioSolutions paid vaxgen $2 million upon execution of the definitive agreem...of returns for our shareholders." About VaxGen vaxgen is a biopharmaceutical company based in South San ...ts that speak only as of the date of this release. vaxgen undertakes no obligation to update publicly any fo...

VaxGen and Raven Terminate Merger Agreement

...n anticipated opposition to the proposed merger by vaxgen stockholders. In addition, VaxGen's Board has with...related equity plan proposals would be rejected by vaxgen stockholders. (Logo: http://www.newscom.com/cgi...on, such that this merger will not be approved." vaxgen intends to open the Special Meeting of Stockholder...

VaxGen Issues Rebuttal to MedCap Letter

...en would represent a fairly disastrous outcome for vaxgen and would view it as a clear signal to sell VaxGen...le are discussed in the addendum to this letter. vaxgen believes these recent communications from MedCap s...way the VaxGen-Raven merger vote any way they can. vaxgen believes this includes the use of flawed arguments...

VaxGen Common Stock Now Quoted on OTC Bulletin Board

...iegel and Company is the market maker and assisted vaxgen with the qualification process. (Logo: http://w...e closing condition to the proposed merger between vaxgen and Raven requiring that VaxGen be listed on an ap...s to vote on the proposed merger. About VaxGen vaxgen is a biopharmaceutical company based in South San ...

Raven Announces RAV12 Phase 1/2a Study Results To Be Presented at ASCO

...tic MAbs for many cancer indications including lung, colon, pancreatic, prostate, breast, brain, and ovarian cancer. On November 12, 2007, Raven and vaxgen Inc. (Pink Sheets: VXGN.PK), a biopharmaceutical company, announced that their respective boards of directors unanimously approved a definitive merger...

VaxGen Reports Financial Update

...gi-bin/prnh/19991112/VAXGENLOGO ) Specifically, vaxgen announced the following: -- Cash, cash equivalent...s current best estimate of fair market value. vaxgen has not yet received an offer for the manufact...tion at this reduced value, or indeed at all. vaxgen expects to file its 2007 financial statements ...

Raven biotechnologies to Provide Updates on Oncology Pipeline With Four AACR Presentations

...herapeutic MAbs for many cancer indications including lung, colon, pancreatic, prostate, breast, and ovarian cancer. On November 12, 2007, Raven and vaxgen Inc. (Pink Sheets: VXGN), a biopharmaceutical company, announced that their respective boards of directors unanimously approved a definitive merger ag...

VaxGen to Present at the 10th Annual BIO CEO and Investor Conference

...ter the live presentation. About VaxGen vaxgen is a biopharmaceutical company based in South San ...ts that speak only as of the date of this release. vaxgen and Raven undertake no obligation to update public...w. Additional Information and Where to Find It vaxgen has filed a registration statement on Form S-4, an...
Other Tags
(Date:7/11/2014)... New York (PRWEB) July 11, 2014 ... ) , filed against Johnson & Johnson’s Ethicon ... Bernstein Liebhard LLP notes that the Texas Attorney ... the company’s marketing of surgical mesh products used ... incontinence. According to a report from kens5.com, the ...
(Date:7/11/2014)... PA (PRWEB) July 11, 2014 Butler Mobility ... of Inclined Platform Lifts . Previously the two ... offering five new beautiful earth tone colors as standard colors ... blend well in the home but will enhance the beauty ... choice for any home color scheme or individual décor. , ...
(Date:7/11/2014)... the number of deer in an area can lower ... infections among people, new research indicates. "Our study ... human interactions with deer, infected nymphal ticks and human ... White-tailed deer are the primary host for adult blacklegged ... study included nearly all the permanent residents of a ...
(Date:7/11/2014)... 2014 (HealthDay News) -- People with the lowest incomes may ... artery disease (PAD), a new study suggests. People with ... the limbs, most often the legs. The condition causes leg ... arteries throughout the body. People with PAD have a higher ... from nearly 6,800 people with PAD who took part in ...
(Date:7/11/2014)... Dennis Thompson HealthDay Reporter ... girl born with HIV who was thought to be cured ... tests showing detectable levels of the AIDS-causing virus in her ... now nearly 4 years old, had remained virus-free even though ... old. Doctors had hoped her remission would open the door ...
Breaking Medicine News(10 mins):Health News:Transvaginal Mesh Lawsuit News: Bernstein Liebhard LLP Notes Report of Texas Probe into Ethicon Pelvic Mesh Marketing 2Health News:Transvaginal Mesh Lawsuit News: Bernstein Liebhard LLP Notes Report of Texas Probe into Ethicon Pelvic Mesh Marketing 3Health News:Transvaginal Mesh Lawsuit News: Bernstein Liebhard LLP Notes Report of Texas Probe into Ethicon Pelvic Mesh Marketing 4Health News:Butler Mobility Products Announces Five New Standard Colors for Their Inclined Platform Lifts 2Health News:Poor More Prone to Leg Circulation Trouble 2Health News:Mississippi Girl Thought Cured of HIV Shows Signs of Infection 2Health News:Mississippi Girl Thought Cured of HIV Shows Signs of Infection 3
(Date:7/11/2014)... Wildlife Conservation Society shows that no-take zones in ... such as lobster, conch, and fish recover from ... areas. , The reporttitled "Review of the Benefits ... literature from no-take areas around the world. The ... recognized expert in marine protected areas and fisheries ...
(Date:7/11/2014)... July 11, 2014--Researchers at the Department of Energy,s ... 100 awards, presented by R&D Magazine in recognition ... "These awards recognize the tremendous value of our ... "Research and development at the National Labs continues ... and pursue the scientific and technological innovations necessary ...
(Date:7/11/2014)... fires burning in eastern New South Wales, Australia when ... At 03:35 UTC on July 11 (12:35 p.m. local ... over eastern New South Wales (NSW), the Moderate Resolution ... of the region and spotted smoke (light brown) from ... bands, are outlined in red. , The New South ...
Breaking Biology News(10 mins):Belize's lobster, conch, and fish populations rebuild in no-take zones 2ORNL wins eight R&D 100s 2ORNL wins eight R&D 100s 3ORNL wins eight R&D 100s 4
Other Contents